Cassava Sciences
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $1,222 | $0 |
Gross Profit | -200 | -220 | 611 | -260 |
EBITDA | -45,174 | -23,183 | -27,337 | -31,464 |
EBIT | -45,392 | -23,403 | -27,597 | -31,723 |
Net Income | -44,224 | -23,403 | -27,597 | -27,943 |
Net Change In Cash | 0 | 0 | 1,222 | 0 |
Free Cash Flow | -4,947 | -11,336 | -61,322 | -18,313 |
Cash | 112,381 | 117,328 | 128,574 | 148,978 |
Basic Shares | 48,308 | 48,262 | 48,099 | 47,976 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $-1 | $0 |
Gross Profit | -1,132 | -89,423 | -1 | -534 |
EBITDA | -23,210 | -95,687 | -78,719 | -32,334 |
EBIT | -24,342 | -97,217 | -80,020 | -32,868 |
Net Income | -24,342 | -97,217 | -72,472 | -31,802 |
Net Change In Cash | 0 | 0 | -1 | 0 |
Cost of Revenue | 139,931 | |||
Free Cash Flow | -117,032 | -82,439 | -80,226 | -52,410 |
Cash | 128,574 | 121,136 | 201,015 | 233,437 |
Basic Shares | 46,604 | 41,932 | 40,202 | 39,405 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.92 |
2025-03-31 | -$0.48 |
2024-12-31 | -$0.57 |
